Myocardial dysfunction in rheumatoid arthritis: A controlled tissue-Doppler echocardiography study

Journal of Rheumatology

Volumn 34, Issue 10, 2007, Pages 2005-2009

  Meune, Christophe ^a   Wahbi, Karim ^a   Assous, Noémie ^a   Weber, Simon ^a   Kahan, André ^a   Allanore, Yannick ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Service de Rhumatologie A ^*  (France)

Author keywords

Myocardial diastolic function; Rheumatoid arthritis; Tissue Doppler echocardiography

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ADULT; ARTHRITIS, RHEUMATOID; ECHOCARDIOGRAPHY, DOPPLER; HEMODYNAMICS; HUMANS; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 35148896940     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Roux Ch, Saraux A, Le Bihan E, et al. Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol 2007;34:117-22.
2. Carmona L, Villaverde V, Hernandez-Garcia C, et al. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology Oxford 2002;41:88-95.
3. Allanore Y. Cardiovascular mortality in patients with inflammatory rheumatic disorders. Joint Bone Spine 2007;74:120-2.
4. Assous N, Touze E, Meune C, Kahan A, Allanore Y. Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Joint Bone Spine 2007;74:66-72.
5. Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999;100:999-1008.
6. Crowson CS, Nicola PJ, Kremers HM, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005;52:3039-44.
7. Di Franco M, Paradiso M, Mammarella A, et al. Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis 2000;59:227-9.
8. Giles JT, Fernandes V, Lima JA, Bathon JM. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005;7:195-207.
9. Palka P, Lange A, Fleming AD, et al. Age-related transmural peak mean velocities and peak velocity gradients by Doppler myocardial imaging in normal subjects. Eur Heart J 1996;17:940-50.
10. Meune C, Pascal O, Becane HM, et al. Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker muscular dystrophy. Heart 2004;90:947-8.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-8.
13. Meune C, Bertherat J, Dousset B, et al. Reduced myocardial contractility assessed by tissue Doppler echocardiography is associated with increased risk during adrenal surgery of patients with pheochromocytoma: report of a preliminary study. J Am Soc Echocardiogr 2006;19:1466-70.
14. Allanore Y, Meune C, Vignaux O, et al. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echography study. J Rheumatol 2006;33:2464-9.
15. Vignaux O, Allanore Y, Meune C, et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 2005;64:1268-73.
16. rd, Strum DP, Mandarino WA, Gulati VK, Pinsky MR. Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Circulation 1997;95:2423-33.
17. Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JAC, Smiseth OA. Quantitative assessment of intrinsic regional myocardial deformation by Doppler Strain Rate echocardiography in humans; validation against three-dimension tagged magnetic resonance imaging. Circulation 2002;106:50-6.
18. Shimizu Y, Uematsu M, Shimizu H, et al. Peak negative myocardial velocity gradient in early diastole as a noninvasive indicator of left ventricular diastolic function: comparison with transmitral flow velocity indices. J Am Coll Cardiol 1998;32:1418-25.
19. Giatrakos N, Kinali M, Stephens D, et al. Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome. Heart 2006;92:840-2.
20. Ganame J, Claus P, Eyskens B, et al. Acute cardiac functional and morphological changes after anthracycline infusions in children. Am J Cardiol 2007;99:974-7.
21. Palka P, Lange A, Fleming AD, et al. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1997;30:760-8.
22. Derumeaux G, Mulder P, Richard V, et al. Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation 2002;105:1602-8.
23. Yu Cm, Sanderson JE, Marwick Th, Oh Jk. Tissue Doppler Imaging: a new prognosticator for cardiovascular disease. J Am Coll Cardiol 2007;49:1903-14.
24. Garcia-Fernandez Ma, Azevedo J, Moreno M, et al. Regional diastolic function in ischaemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J 1999;20:496-505.
25. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004;116:305-11.